- Home
- UPXI vs LNZA Comparison
UPXI vs LNZA Comparison
Compare UPXI & LNZA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UPXI | LNZA |
|---|---|---|
| Founded | 2018 | 2005 |
| Country | United States | United States |
| Employees | 59 | 192 |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2M | 66.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | UPXI | LNZA |
|---|---|---|
| Price | $0.87 | $6.42 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $2.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 2.2M | 274.1K |
| Earning Date | 05-15-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.49 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,811,345.00 | N/A |
| Revenue This Year | $118.99 | $55.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.54 | $0.24 |
| 52 Week High | $10.62 | $44.00 |
Technical Indicators
Market Signals| Indicator | UPXI | LNZA |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 41.53 |
| Support Level | $0.74 | $5.22 |
| Resistance Level | $1.15 | $8.29 |
| Average True Range (ATR) | 0.09 | 1.00 |
| MACD | 0.01 | 0.55 |
| Stochastic Oscillator | 33.59 | 45.48 |
Price Performance
Historical ComparisonAbout UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana. Geographically, the company generates the majority of its revenue from the United States.
About LNZA LanzaTech Global Inc.
LanzaTech Global Inc is a provider of carbon management and conversion technologies, focused on transforming waste materials into high-value fuels, chemicals, and critical industrial inputs. Its mission is to drive energy resilience, industrial competitiveness, and supply chain security by leveraging scalable biotechnology solutions to maximize the value of domestic resources. The company operates in North America, Europe, the Middle East, Africa (EMEA), Asia, and Australia, with the majority of its revenue generated from North America.